Figure 1.
Kaplan–Meier curve of LRFS for patients undergoing BCT±RT or MX followed by either adjuvant tamoxifen or a tamoxifen/anastrozole sequence during 5 years. >50% of all patients had a high-risk cancer lesion measured by EP genetic expression score. EndoPredict high-risk lesions had a significant higher local recurrence rate (P=0.008).